Open Access

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

  • M. P. Snee1,
  • L. McParland2,
  • F. Collinson2,
  • C. M. Lowe2,
  • A. Striha2,
  • D. R. Baldwin3,
  • B. Naidu4,
  • D. Sebag-Montefiore1, 6,
  • W. M. Gregory2,
  • J. Bestall5,
  • J. Hewison5,
  • S. Hinsley2 and
  • K. N. Franks1Email author
Pilot and Feasibility Studies20162:55

DOI: 10.1186/s40814-016-0095-6

Published: 12 September 2016

The original article was published in Pilot and Feasibility Studies 2016 2:5

Erratum

After publication of the original article [1], it came to the authors’ attention that a source of funding had been inadvertently omitted from the Acknowledgements section; support from Yorkshire Cancer Research should have mentioned originally.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust
(2)
Clinical Trials Research Unit (CTRU), Leeds Institute of Clinical Trials Research, University of Leeds
(3)
Respiratory Medicine Unit, David Evans Research Centre, Nottingham University Hospitals and University of Nottingham
(4)
School of Clinical and Experimental Medicine, University of Birmingham
(5)
Leeds Institute of Health Sciences, Faculty of Medicine and Health, University of Leeds
(6)
Leeds Institute of Cancer and Pathology, Faculty of Medicine and Health, University of Leeds

Reference

  1. Snee MP, McParland L, Collinson F, Lowe CM, Striha A, Baldwin DR, et al. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection. Pilot Feasability Studies. 2016;2:5. doi:10.1186/s40814-016-0046-2.View ArticleGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement